Effectiveness and Safety of Intermittent Preventive Treatment for Malaria Using Either Dihydroartemisinin-piperaquine or Artesunate-amodiaquine in Reducing Malaria Related Morbidities and Improving Cognitive Ability in School-aged Children in Tanzania
Clinical trial NCT03640403 · COMPLETED
Trial details
- NCT number
- NCT03640403
- Sponsor
- National Institute for Medical Research, Tanzania
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-26
- Primary completion
- 2020-12-31
- Enrollment
- 1555
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.